The new model of access strategy should build around four key pillars, says Jeff Weisel, Senior Advisor Asia-Pacific, PRMA Consulting. In this update, Jeff explores why the shifting currents of global healthcare are dictating a new approach to market access. Continue Reading
Developing innovative pharmaceutical products is a lengthy process with no guarantee of success at the end. Manufacturers struggle with coordinating strategy internally and incorporating multiple payer requirements in clinical development programs. In the fourth of her five-part series on digital… Continue Reading
In the first of her five-part series on digital transformation in market access, Dr Patti Peeples, CEO of HealthEconomics.com, sits down with Claire Chadwick, HTA Manager at PRMA Consulting. Continue Reading
